Should we offer HRT to ovarian and endometrial cancer survivors? Yes. There is no scientifically valid reason not to do so

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)31-32+34
JournalEmergency Medicine
Volume46
Issue number9
StatePublished - Sep 1 2001

ASJC Scopus subject areas

  • Emergency Medicine

Cite this